Phase 1 Trial of ABT-888 and SCH727965 in Patients With Advanced Solid Tumors

Trial Profile

Phase 1 Trial of ABT-888 and SCH727965 in Patients With Advanced Solid Tumors

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 May 2017

At a glance

  • Drugs Carboplatin (Primary) ; Dinaciclib (Primary) ; Veliparib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Jan 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
    • 03 Nov 2015 According to ClinicalTrials.gov record, the treatment table has been amended.
    • 03 Nov 2015 Planned number of patients changed from 116 to 130, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top